Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Richard Klausner, Gregory Lucier, Mark DePristo

Premium

Illumina has appointed Richard Klausner to senior vice president and Chief Medical Officer, where he will lead Illumina's strategies for advancing genomics into clinical medicine and public health.

Preivously, Klausner was managing partner of the Column Group, a venture capital firm. He has also served as executive director of the Bill and Melinda Gates Foundation, director of the National Cancer Institute, chief of the cell biology and metabolism branch of the National Institute of Child Health and Human Development, and is a past president of the American Society of Clinical Investigation.

He holds an MD from Duke Medical School.


Gregory Lucier has been appointed to the board of directors at RainTree Oncology and has been elected chairman of the board at Sanford-Burnham Medical Research Institute.

Lucier is CEO and chairman of Life Technologies. He also serves on the boards of CareFusion Corporation, Synthetic Genomics, and Rady Children's Hospital. He holds a BS in engineering from Pennsylvania State University and an MBA from Harvard Business School.


SynapDx has appointed Mark DePristo to vice president of informatics. DePristo joins the company from the Broad Institute where he served as co-director of medical and population genetics. His team at the Broad created the Genome Analysis Toolkit. He holds a PhD in biochemistry from Cambridge University and a BA in computer science and mathematics from Northwestern University.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.